SCHEMBL4222291

SCHEMBL4222291

COc1ccc(OC)c(C(=O)c2ccccc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.84
HTT P42858 3/20 0.84
NPSR1 Q6W5P4 1/20 0.84
ALDH1A1 P00352 4/20 0.79
POLB P06746 2/20 0.72
LMNA P02545 4/20 0.67
HPGD P15428 3/20 0.67
MAPK1 P28482 2/20 0.67
CYP1A2 P05177 1/20 0.67
PGR P06401 1/20 0.67
CYP2D6 P10635 1/20 0.67
SLC6A2 P23975 1/20 0.67
PDE4A P27815 1/20 0.67
CYP2C19 P33261 1/20 0.67
HRH1 P35367 1/20 0.67
SLC6A3 Q01959 1/20 0.67
PDE4D Q08499 1/20 0.67
CYP2C9 P11712 1/20 0.63
RXFP1 Q9HBX9 1/20 0.63
RAB9A P51151 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6375687 0.90 MAPT (0.96) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL15106689 0.88 MAPT (0.65) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL3224251 0.87 NPC1 (0.81) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL4049476 0.87 MAPT (0.64) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL30205105 0.87 NPC1 (0.81) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL12228747 0.86 MAPT (0.82) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL29229968 0.85 NPC1 (0.69) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL23409046 0.85 MAPT (0.61) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL5990725 0.85 MAPT (0.61) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL30070804 0.85 MAPT (0.61) MAPTHTTNPSR1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2803069-B1 HOLOGRAPHIC RECORDING MEDIUM AND METHOD OF MAKING HOLOGRAPHIC RECORDING MEDIUM SABIC INNOVATIVE PLASTICS IP (NL) 2016-02-03 EP disclosed
US-8663873-B2 Holographic recording medium and method of recording a hologram SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-03-04 US disclosed
US-8663873-B2 Holographic recording medium and method of recording a hologram SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-03-04 US disclosed
WO-2013106138-A1 HOLOGRAPHIC RECORDING MEDIUM AND METHOD OF MAKING HOLOGRAPHIC RECORDING MEDIUM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2013-07-18 WO disclosed
US-20130183608-A1 HOLOGRAPHIC RECORDING MEDIUM AND METHOD OF MAKING HOLOGRAPHIC RECORDING MEDIUM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2013-07-18 US disclosed
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use MERCK SHARP & DOHME CORP. 2009-08-06 US disclosed
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use MERCK SHARP & DOHME CORP. 2009-08-06 US disclosed
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use MERCK SHARP & DOHME CORP. 2009-08-06 US disclosed
EP-1858513-A4 DIPHENYL SUBSTITUTED CYCLOALKANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 2009-06-03 EP disclosed
US-20080274425-A1 Multilayeer; aluminum support with fluoroalkyl acrylic group containing polymer; alkali soluble resin and an acid generator KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-11-06 US disclosed
US-20080182202-A1 Planographic printing plate material and resin used therein KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-07-31 US disclosed
US-20080160445-A1 Planographic printing plate material, and method of preparing planographic printing plate employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-07-03 US disclosed
US-20080131812-A1 Resin for printing plate material and lithographic printing plate material by use thereof KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-06-05 US disclosed
EP-1858513-A1 DIPHENYL SUBSTITUTED CYCLOALKANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2007-11-28 EP disclosed
WO-2006098912-A1 DIPHENYL SUBSTITUTED CYCLOALKANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2006-09-21 WO disclosed
EP-0911153-B1 Image forming method KONISHIROKU PHOTO IND (JP) 2003-12-10 EP disclosed
US-6174646-B1 IMAGEWISE HEATING OR EXPOSING IMAGE FORMING MATERIAL TO LASER WHEREIN IMAGE FORMING MATERIAL COMPRISES SUPPORT HAVING RADIATION SENSITIVE LAYER CONTAINING DYE, AN ACID GENERATING COMPOUND CAPABLE OF GENERATING ACID ON IRRADIATION KONICA CORPORATION (JP) 2001-01-16 US disclosed
EP-0911153-A1 Image forming method KONICA CORPORATION (JP) 1999-04-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use ALOX5, LTC4S, ALOX15B MAPT 4739/4885HTT 3792/4885NPSR1 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.